Form 485BPOS DEUTSCHE DWS SECURITIES
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260429/AVZZE222Z22GD2Y2222E2WZ2U3UQZZ2I2L82
Filed on: April 29, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Protagonist Therapeutics Announces U.S. FDA Approval of Hepcidin Mimetic Peptide MIMRYLO(TM) (rusfertide) for Polycythemia Vera
- UpStart Investments Files for TSXV Conditional Approval
- Acceleware Ltd. Reports Second Quarter 2026 Financial and Operating Results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
